Back to Search
Start Over
An additional physiological role for HSP70: Assistance of vascular reactivity.
- Source :
-
Life sciences [Life Sci] 2020 Sep 01; Vol. 256, pp. 117986. Date of Electronic Publication: 2020 Jun 23. - Publication Year :
- 2020
-
Abstract
- Aims: HSP70, a molecular chaperone, helps to maintain proteostasis. In muscle biology, however, evidence suggests HSP70 to have a more versatile range of functions, as genetic deletion of its inducible genes impairs Ca <superscript>2+</superscript> handling, and consequently, cardiac and skeletal muscle contractility. Still, it is unknown whether HSP70 is involved in vascular reactivity, an intrinsic physiological mechanism of blood vessels. Therefore, we designed this study to test the hypothesis that proper vascular reactivity requires the assistance of HSP70.<br />Main Methods: We performed functional studies in a wire-myograph using thoracic aorta isolated from male Sprague Dawley rats. Experiments were conducted with and without an HSP70 inhibitor as well as in heat-stressed vessels. The expression levels of HSP70 were evaluated with Western blotting. NO and ROS levels were assessed with fluorescence microscopy.<br />Key Findings: We report that blockade of HSP70 weakens contraction in response to phenylephrine (dose-response) in the aorta. Additionally, we demonstrated that inhibition of HSP70 affects the amplitude of the fast and of the slow components of the time-force curve. Corroborating these findings, we found that inhibition of HSP70, in vessels over-expressing this protein, partly rescues the contractile phenotype of aortic rings. Furthermore, we show that blockade of HSP70 facilitates relaxation in response to acetylcholine and clonidine without affecting the basal levels of NO and ROS.<br />Significance: Our work introduces an additional physiological role for HSP70, the assistance of vascular reactivity, which highlights this protein as a new player in vascular physiology, and therefore, uncovers a promising research avenue for vascular diseases.<br />Competing Interests: Declaration of competing interest Both authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.<br /> (Copyright © 2020 Elsevier Inc. All rights reserved.)
- Subjects :
- Acetylcholine pharmacology
Animals
Aorta, Thoracic drug effects
Dose-Response Relationship, Drug
Endothelium, Vascular drug effects
HSP70 Heat-Shock Proteins agonists
HSP70 Heat-Shock Proteins antagonists & inhibitors
Male
Muscle, Smooth, Vascular drug effects
Organ Culture Techniques
Phenylephrine pharmacology
Purine Nucleosides pharmacology
Rats
Rats, Sprague-Dawley
Vasoconstrictor Agents pharmacology
Vasodilator Agents pharmacology
Aorta, Thoracic physiology
Endothelium, Vascular physiology
HSP70 Heat-Shock Proteins physiology
Muscle, Smooth, Vascular physiology
Subjects
Details
- Language :
- English
- ISSN :
- 1879-0631
- Volume :
- 256
- Database :
- MEDLINE
- Journal :
- Life sciences
- Publication Type :
- Academic Journal
- Accession number :
- 32585245
- Full Text :
- https://doi.org/10.1016/j.lfs.2020.117986